NPORT-EX 2 smallcap-nport.htm NPORT-EX

Investment Portfolio
        
(UNAUDITED) | 01.31.2021
        
CARILLON SCOUT SMALL CAP FUND
        
COMMON STOCKS - 99.6%
  
Shares
    
Value
  
Aerospace & defense - 1.6%
        
Kratos Defense & Security Solutions, Inc.*
    
243,820
    
$
6,470,983
  
Air freight & logistics - 0.9%
          
Forward Air Corp.
    
51,976
      
3,726,159
  
Auto components - 1.4%
          
Patrick Industries, Inc.
    
18,203
      
1,257,099
  
Stoneridge, Inc.*
    
163,379
      
4,484,754
  
Automobiles - 1.4%
          
Thor Industries, Inc.
    
48,582
      
5,878,908
  
Banks - 0.8%
          
Hilltop Holdings, Inc.
    
111,486
      
3,349,039
  
Biotechnology - 7.6%
          
Coherus Biosciences, Inc.*
    
182,303
      
3,427,296
  
Eagle Pharmaceuticals, Inc.*
    
76,943
      
3,590,930
  
Halozyme Therapeutics, Inc.*
    
176,785
      
8,413,198
  
Insmed, Inc.*
    
170,676
      
6,415,711
  
Vericel Corp.*
    
230,830
      
9,526,354
  
Capital markets - 1.8%
          
Cohen & Steers, Inc.
    
95,480
      
6,253,940
  
Open Lending Corp., Class A*
    
31,451
      
1,141,357
  
Chemicals - 1.2%
          
Balchem Corp.
    
47,500
      
5,083,925
  
Commercial services & supplies - 0.9%
          
Healthcare Services Group, Inc.
    
117,711
      
3,816,191
  
Construction & engineering - 1.3%
          
Dycom Industries, Inc.*
    
64,018
      
5,194,421
  
Consumer finance - 2.5%
          
Green Dot Corp., Class A*
    
54,384
      
2,731,709
  
LendingTree, Inc.*
    
16,587
      
5,399,400
  
PRA Group, Inc.*
    
73,126
      
2,410,964
  
Electrical equipment - 2.4%
          
TPI Composites, Inc.*
    
165,118
      
9,892,219
  
Electronic equipment, instruments & components - 5.6%
          
ePlus, Inc.*
    
51,242
      
4,306,378
  
Fabrinet*
    
61,435
      
4,849,679
  
II-VI, Inc.*
    
113,207
      
9,517,312
  
Plexus Corp.*
    
59,260
      
4,558,279
  
Energy equipment & services - 0.3%
          
Core Laboratories N.V.
    
40,999
      
1,352,147
  
Equity real estate investment trusts (REITs) - 1.7%
          
CareTrust REIT, Inc.
    
137,439
      
3,086,880
  
QTS Realty Trust, Inc., Class A
    
62,055
      
4,039,780
  
Food & staples retailing - 1.4%
          
Performance Food Group Co.*
    
126,692
      
5,939,321
  
Health care equipment & supplies - 4.7%
          
Cantel Medical Corp.*
    
42,963
      
3,392,788
  
ICU Medical, Inc.*
    
27,740
      
5,672,275
  
Integer Holdings Corp.*
    
68,202
      
5,033,308
  
LeMaitre Vascular, Inc.
    
74,877
      
3,598,589
  
Varex Imaging Corp.*
    
99,026
      
1,917,143
  
Health care providers & services - 10.6%
          
AdaptHealth Corp.*
    
218,249
      
8,352,389
  
AMN Healthcare Services, Inc.*
    
95,499
      
6,887,388
  
BioTelemetry, Inc.*
    
48,742
      
3,483,103
  
HealthEquity, Inc.*
    
86,798
      
7,251,973
  
LHC Group, Inc.*
    
42,234
      
8,413,858
  
ModivCare, Inc.*
    
20,673
      
3,278,118
  
U.S. Physical Therapy, Inc.
    
54,049
      
6,504,257
  
Health care technology - 3.2%
          
HMS Holdings Corp.*
    
70,038
      
2,578,799
  
Omnicell, Inc.*
    
90,844
      
10,701,423
  
Hotels, restaurants & leisure - 2.2%
          
Cracker Barrel Old Country Store, Inc.
    
24,552
      
3,322,131
  
Lindblad Expeditions Holdings, Inc.*
    
161,060
      
2,528,642
  
The Cheesecake Factory, Inc.
    
75,410
      
3,391,188
  
Household durables - 3.4%
          
Installed Building Products, Inc.*
    
66,337
      
6,960,741
  
iRobot Corp.*
    
11,451
      
1,375,265
  
LGI Homes, Inc.*
    
54,052
      
5,767,889
  
Insurance - 0.7%
          
CNO Financial Group, Inc.
    
137,939
      
2,925,686
  
Internet & direct marketing retail - 3.2%
          
Magnite, Inc.*
    
334,814
      
11,597,957
  
PetMed Express, Inc. (a)
    
46,599
      
1,780,082
  
IT Services - 1.1%
          
I3 Verticals, Inc., Class A*
    
155,914
      
4,524,624
  
Life sciences tools & services - 6.9%
          
Bruker Corp.
    
133,152
      
7,708,169
  
Medpace Holdings, Inc.*
    
60,484
      
8,031,670
  
NeoGenomics, Inc.*
    
126,632
      
6,714,029
  
PRA Health Sciences, Inc.*
    
51,763
      
6,379,272
  
Machinery - 5.5%
          
Albany International Corp., Class A
    
58,789
      
4,087,011
  
Chart Industries, Inc.*
    
85,409
      
10,258,475
  
Proto Labs, Inc.*
    
39,558
      
8,378,385
  
Pharmaceuticals - 1.2%
          
Supernus Pharmaceuticals, Inc.*
    
168,408
      
4,949,511
  
Professional services - 1.4%
          
Insperity, Inc.
    
72,539
      
5,693,586
  
Semiconductors & semiconductor equipment - 8.1%
          
Advanced Energy Industries, Inc.*
    
46,677
      
4,788,127
  
Ambarella, Inc.*
    
59,817
      
5,644,332
  
Impinj, Inc.*
    
77,322
      
4,095,746
  
Inphi Corp.*
    
39,519
      
6,663,299
  
Power Integrations, Inc.
    
70,312
      
5,663,632
  
Semtech Corp.*
    
98,391
      
6,980,841
  
Software - 9.1%
          
Box, Inc., Class A*
    
199,682
      
3,462,486
  
Envestnet, Inc.*
    
66,012
      
5,065,101
  
J2 Global, Inc.*
    
61,998
      
6,363,475
  
Qualys, Inc.*
    
40,877
      
5,660,238
  
The Descartes Systems Group, Inc.*
    
98,511
      
6,015,082
  
Upland Software, Inc.*
    
122,914
      
5,861,769
  
Verint Systems, Inc.*
    
71,779
      
5,299,443
  
Specialty retail - 1.2%
          
Monro, Inc.
    
83,024
      
4,854,413
  
Textiles, apparel & luxury goods - 1.0%
          
G-III Apparel Group Ltd.*
    
161,106
      
4,356,306
  
Thrifts & mortgage finance - 1.0%
          
Axos Financial, Inc.*
    
103,938
      
4,048,385
  
Trading companies & distributors - 2.3%
          
Applied Industrial Technologies, Inc.
    
57,830
      
4,070,654
  
Systemax, Inc.
    
139,245
      
5,351,185
  
Total common stocks (cost $217,856,479)
      
413,798,571
  
                 
MONEY MARKET FUNDS - 0.0%
          
First American Government Obligations Fund - Class X, 0.04%#
    
3,120
      
3,120
  
Total money market funds (cost $3,120)
      
3,120
  
Total Investment portfolio (cost $217,859,599) - 99.6%
      
413,801,691
  
Other assets in excess of liabilities - 0.4%
      
1,534,414
  
Total net assets - 100.0%
    
$
415,336,105
  

* Non-income producing security
      
(a) All or a portion of this security was on loan as of the date of this report. The total fair market value of loaned securities was $3,056 or 0.0% of net assets as of the date of this report.
 # Annualized seven-day yield as of the date of this report. Investment made with cash collateral received for securities on loan.
 
Fair value measurements | The Fund utilizes a three-level hierarchy of inputs to establish a classification of fair value measurements. The three levels are defined as:
Level 1—Valuations based on unadjusted quoted prices for identical securities in active markets;
Level 2—Valuations based on inputs other than quoted prices that are observable, either directly or indirectly, including inputs in markets that are not considered active; and
Level 3—Valuations based on inputs that are unobservable and significant to the fair value measurement, and may include the Valuation Committee’s own assumptions on determining fair value of investments.
         
Inputs that are used in determining fair value of an investment may include price information, credit data, volatility statistics, and other factors. These inputs can be either observable or unobservable. The availability of observable inputs can vary between investments and is affected by various factors such as the type of investment and the volume and/or level of activity for that investment or similar investments in the marketplace. The inputs will be considered by the Valuation Committee, along with any other relevant factors in the calculation of an investment’s fair value. The Fund uses prices and inputs that are current as of the valuation date, which may include periods of market dislocations. During these periods, the availability of prices and inputs may be reduced for many investments. This condition could cause an investment to be reclassified between the various levels within the hierarchy. Investments falling into the Level 3 category may be classified as such due to a lack of market transparency and corroboration to support the quoted prices. Additionally, valuation models may be used as the pricing source for any remaining investments classified as Level 3. These models may rely on one or more significant unobservable inputs and/or significant assumptions by the Valuation Committee. Inputs used in valuations may include, but are not limited to, financial statement analysis, capital account balances, discount rates and estimated cash flows, and comparable entity data.
         
All investments are categorized as Level 1 as of the date of this report.
         
For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual or annual report.
         
The Global Industry Classification Standard (GICS®) was developed by and/or is the exclusive property of Morgan Stanley Capital International, Inc. (“MSCI”) and Standard & Poor’s Financial Services LLC (“S&P”). GICS is a service mark of MSCI and S&P and has been licensed for use by U.S. Bancorp Fund Services, LLC.